CAR-T cell therapies infused into brain shrink tumors in two glioblastoma studies
Two groups of researchers say that experimental CAR-T cell therapies have shrunk tumors in a matter of days in patients with recurrent glioblastoma, a deadly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.